Patents/Assignees

Dicerna Pharmaceuticals, Inc.

27 patents in portfolio

US11634713utility2023
Extended Dicer Substrate Agents and Methods for the Specific Inhibition of Gene Expression
0 cites
US11634715utility2023
Methods and Compositions for Treating Bile Duct Paucity-associated Conditions
0 cites
US11597929utility2023
Extended Dicer Substrate Agents and Methods for the Specific Inhibition of Gene Expression
0 cites
US11578329utility2023
Compositions and Methods for Inhibiting Nuclear Receptor Subfamily 1 Group H Member 3 (NR1H3) Expression
0 cites
US11572559utility2023
Reducing Beta-catenin Expression to Potentiate Immunotherapy
0 cites
US11572562utility2023
Compositions and Methods for Inhibiting GYS2 Expression
0 cites
US11566248utility2023
PCSK9 Targeting Oligonucleotides for Treating Hypercholesterolemia and Related Conditions
0 cites

← PreviousPage 2 of 2